# ClinicalTrials.gov record NCT05663515

> PeptideScanner retained ClinicalTrials.gov record NCT05663515 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct05663515-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-04
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05663515-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05663515-exenatide-v1.json
- Content SHA-256: `d7a0f108ba294bf5069983420b123c1e11698943717aa70776e03b936d92b559`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05663515 ([`ctg-observation-nct05663515-2026-08-04-c1bd074f72a5`](#source-ctg-observation-nct05663515-2026-08-04-c1bd074f72a5))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05663515 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct05663515-2026-08-04-c1bd074f72a5`](#source-ctg-observation-nct05663515-2026-08-04-c1bd074f72a5))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05663515 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct05663515-2026-08-04-c1bd074f72a5`](#source-ctg-observation-nct05663515-2026-08-04-c1bd074f72a5))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05663515-2026-08-04-c1bd074f72a5`](#source-ctg-observation-nct05663515-2026-08-04-c1bd074f72a5))

## Sources

<a id="source-ctg-observation-nct05663515-2026-08-04-c1bd074f72a5"></a>
- **ClinicalTrials.gov record NCT05663515 · retained source version 2026-08-04:c1bd074f72a5d779597ace59cb9f39678d1183bb902c2a8081822a2a21190388** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05663515) (`ctg-observation-nct05663515-2026-08-04-c1bd074f72a5`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05663515." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05663515-exenatide-v1.json SHA-256: d7a0f108ba294bf5069983420b123c1e11698943717aa70776e03b936d92b559.